Dr. Stephen V. Liu
Claim this profileMedStar Georgetown University Hospital
Area of expertise
Lung Cancer
Stephen V. Liu has run 10 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Stephen V. Liu has run 8 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
MedStar Georgetown University Hospital
MedStar Washington Hospital Center
Clinical Trials Stephen V. Liu is currently running
Durvalumab + Tremelimumab with Chemotherapy
for Non-Small Cell Lung Cancer
This is a phase II trial of durvalumab and tremelimumab in combination of platinum-based chemotherapy. Patients with stage IV Non-Small-Cell-Lung Cancer (NSCLC) with human immunodeficiency virus (HIV) infection will be eligible. Patients will receive standard platinum-based chemotherapy plus durvalumab for 4 cycles (every 3 weeks), followed by durvalumab (with or without pemetrexed for non-squamous NSCLC) maintenance therapy. It is hypothesized that Durvalumab and tremelimumab in combination with standard chemotherapy is safe and effective for the treatment of stage IV NSCLC in patients with HIV infection.
Recruiting
1 award
Phase 2
18 criteria
Repotrectinib
for Solid Tumors
Phase 1 dose escalation will determine the first cycle dose-limiting toxicities (DLTs), the maximum tolerated dose (MTD), the biologically effective dose and recommended Phase 2 dose (RP2D) of repotrectinib given to adult subjects with advanced solid malignancies harboring an ALK, ROS1, NTRK1, NTRK2, or NTRK3 gene rearrangement. Midazolam DDI substudy will examine effect of of repotrectinib on CYP3A induction. Phase 2 will determine the confirmed Overall Response Rate (ORR) as assessed by Blinded Independent Central Review (BICR) of repotrectinib in each subject population expansion cohort of advanced solid tumors that harbor a ROS1, NTRK1, NTRK2, or NTRK3 gene rearrangement. The secondary objective will include the duration of response (DOR), time to response (TTR), progression-free survival (PFS), overall survival (OS) and clinical benefit rate (CBR) of repotrectinib in each expansion cohort of advanced solid tumors that harbor a ROS1, NTRK1, NTRK2, or NTRK3 gene rearrangement.
Recruiting
1 award
Phase 1 & 2
7 criteria
More about Stephen V. Liu
Clinical Trial Related
9 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Stephen V. Liu has experience with
- Pembrolizumab
- Carboplatin
- Nivolumab
- Paclitaxel
- Pemetrexed
- Atezolizumab
Breakdown of trials Stephen V. Liu has run
Lung Cancer
Non-Small Cell Lung Cancer
Solid Tumors
Metastatic Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephen V. Liu specialize in?
Stephen V. Liu focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Stephen V. Liu currently recruiting for clinical trials?
Yes, Stephen V. Liu is currently recruiting for 3 clinical trials in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Stephen V. Liu has studied deeply?
Yes, Stephen V. Liu has studied treatments such as Pembrolizumab, Carboplatin, Nivolumab.
What is the best way to schedule an appointment with Stephen V. Liu?
Apply for one of the trials that Stephen V. Liu is conducting.
What is the office address of Stephen V. Liu?
The office of Stephen V. Liu is located at: MedStar Georgetown University Hospital, Washington, District of Columbia 20007 United States. This is the address for their practice at the MedStar Georgetown University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.